Skip to content
healthcare.dev

Lamotrigine

NDC 16571-785, Lamotrigine, tablet, chewable, from Rising Pharma Holdings, Inc..

Product NDC
16571-785
Status
Listed
Labeler
Rising Pharma Holdings, Inc.
Dosage form
TABLET, CHEWABLE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA090401
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/16571-785 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LAMOTRIGINE5 mg/1

Pharmacologic classes

Anti-epileptic Agent [EPC]; Decreased Central Nervous System Disorganized Electrical Activity [PE]; Dihydrofolate Reductase Inhibitors [MoA]; Mood Stabilizer [EPC]; Organic Cation Transporter 2 Inhibitors [MoA]

Package NDCNDC-11Package
16571-785-0116571078501100 TABLET, CHEWABLE in 1 BOTTLE (16571-785-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/f54690b3-bcbb-4d94-95b9-b7591af00117
  • NADAC price for package 16571078501

    GET /v1/drugs/nadac/16571078501

Use it

Look up 16571-785 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/16571-785 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 16571-785. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.